TriSalus Life Sciences, Inc. (TLSI): 13 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Feb 23, 2026 | Stansky Michael P Director | 361,098 | $4.10 | $1.5M | no history |
| Feb 23, 2026 | Szela Mary T Director, Officer | 30,487 | $4.10 | $125.0K | no history |
| Feb 23, 2026 | Valle William Director | 30,487 | $4.10 | $125.0K | no history |
| Feb 23, 2026 | Gordon Gary B. Director | 9,756 | $4.10 | $40.0K | no history |
| Feb 23, 2026 | Patience David Officer | 3,657 | $4.10 | $15.0K | no history |
| Feb 6, 2025 | Young James Emmett Officer | 6,000 | $5.65 | $33.9K | no history |
| Jan 31, 2025 | Szela Mary T Director, Officer | 10,040 | $5.15 | $51.8K | no history |
| Jan 29, 2025 | Young James Emmett Officer | 24,000 | $5.40 | $129.6K | no history |
| Jan 29, 2025 | Murphy Sean Director, Officer | 30,000 | $5.24 | $157.2K | no history |
| Jan 29, 2025 | Szela Mary T Director, Officer | 9,542 | $5.27 | $50.3K | no history |
| Dec 19, 2024 | Frankenius Equity AB TenPercentOwner | 62,972 | $3.97 | $250.0K | no history |
| Nov 25, 2024 | Wahlstrom Mats Director, TenPercentOwner | 5,000 | $4.55 | $22.8K | no history |
| Nov 22, 2024 | Wahlstrom Mats Director, TenPercentOwner | 10,727 | $4.39 | $47.1K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.